Uterine Fibroids
📧 Sign up to get email alerts when something new happens for Uterine Fibroids.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2020-11-13Ulipristal acetate for uterine fibroids: EMA recommends restricting use
EMA recommends restricting the use of ulipristal acetate for uterine fibroids due to safety concerns.
-
EMA safety_alert · 2020-03-13Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk
EMA suspended Ulipristal acetate for uterine fibroids while reviewing risk of severe liver injury.
-
EMA safety_alert · 2018-05-18PRAC recommends new measures to minimise risk of rare but serious liver injury with Esmya for fibroids
The Pharmacovigilance Risk Assessment Committee (PRAC) recommends new measures to minimize the risk of rare but serious liver injury with Es…
-
EMA safety_alert · 2018-02-09Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
EMA recommends regular liver function tests for women taking Esmya (ulipristal acetate) during ongoing review of the medicine.